Fred K. Friedman

Cancer Institute (WIA)India

Pharmacology, Toxicology and Pharmaceutics · Life Sciences

28h-index2.8kcitations137works0.02yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?


Research Topics

Pharmacogenetics and Drug Metabolism(49), Cancer-related Molecular Pathways(23), Monoclonal and Polyclonal Antibodies Research(16), Hemoglobin structure and function(14), Protein Kinase Regulation and GTPase Signaling(12)

Publications137 total

Journal of Pain and Symptom Management·2022· 1 cited
UNC Libraries·2020Open Access
V&R unipress eBooks·2014· 1 citedOpen Access
PNC-27 and PNC-28 anticancer peptides selectively kill cancer cells by pore formation dependent on the binding of these peptides to hdm2 in cancer cell membranes.
Cancer Research·2008· 1 cited
Site-specific phosphorylation of raf in cells containing oncogenic ras-p21 is likely mediated by jun-N-terminal kinase.
PubMed·2008· 3 cited
Frontiers in bioscience·2004· 4 citedOpen Access
Methods in enzymology on CD-ROM/Methods in enzymology·2003· 1 cited
page 1 of 7Next →

Frequent Co-authors

Matthew R. Pincus(20), Paul W. Brandt‐Rauf(12), Harry V. Gelboin(9), Richard C. Robinson(8), Renke Dai(8), Victor Adler(6), Ze’ev A. Ronai(6), Denise Chung(6), Aditya P. Koley(5), James Chen(5), Josef Michl(5), Ziro Yamaizumi(5), Allen Markowitz(4), Robert E. Vestal(4), Richard Robinson(4), Robert Robinson(4), Regina Monaco(4), Suoping Zhai(3), Robert L. Fine(3), H V Gelboin(3)